NCT04452955
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04452955
Title A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Intra-IMMUSG Pte Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.